Science of Aging is Paul House, a writer and investor inspired by the science of aging and related therapies. Paul House writes for Science of Aging.com which analyzes advances in biological aging and potential therapies. As an investor, Paul focuses on emerging stem cell and regenerative medicine companies. He believes we should invest in what we believe in as well as what might turn a profit and exceptionally high returns.
I try to carefully trade weekly & monthly stock options with expertise in mining companies & traditional manufacturers. Speak & write fluent Portuguese and speak good Spanish. Resided twice in Brazil and once on Guam Island. Employed at the same large foreign-owned Distribution Center the past 15 years & completely 100% Pro-NAFTA. Smart individual investing is the preferred solution to improving one's economic future, as opposed to vast & vague government handouts. Seeking Alpha is the #1 best financial blog because of honest opinions & superb organization.
Over fifteen years of investing experience with both long and short-term objectives. Seeking Alpha can be a great space for intelligent and informed discussion, and a useful resource for investors. Generally consider myself a value investor and occasional trader. Preference for fundamental analysis then soft/empirical analysis both for short and long-term trading/investing. My background is in small business management, accounting, and finance.
I am a Special Ed teacher with 30 years teaching experience. I recently attained the young age of 54 , and like to invest in natural resources, medical devices and, and recently bonds. Major focus at this point is biotechnology, technology, and long term reliable dividend - paying stocks. I like world travel, sports, classical rock music and playing my awesome 12 string Breedlove guitar. I aspire to be the guy who can make money in all markets, just like the big boys.
Capital Markets consultant and active investor in the emerging life science space. Tenured futures trader. Able to provide access to a pool of investors and traders throughout the US and UK. ProActive Capital, a capital markets advisory firm that makes direct investments and provides advisory services into public and private life science companies. Areas of focus include; capital introduction, shareholder management, communications and investor outreach.
Have been an investor for 60 years. Last 20 years have concentrated on biotechs. Have been senior exec with Shell and ITT before retiring 30+ years ago. My working areas were finance, informatics and international management. Taught MBA courses in management, informatics and communications. Speak French and Spanish plus some German.